Telix Pharmaceuticals (Telix Pharmaceuticals) Change In Inventory : $0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Telix Pharmaceuticals Change In Inventory?

Telix Pharmaceuticals's change in inventory for the quarter that ended in Dec. 2023 was $0.0 Mil. It means Telix Pharmaceuticals's inventory stayed the same from Jun. 2023 to Dec. 2023 .

Telix Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2023 was $0.0 Mil. It means Telix Pharmaceuticals's inventory stayed the same from Dec. 2022 to Dec. 2023 .

Telix Pharmaceuticals's Total Inventories for the quarter that ended in Dec. 2023 was $11.6 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Telix Pharmaceuticals's Days Inventory for the quarter that ended in Dec. 2023 was 25.21.

Inventory Turnover measures how fast the company turns over its inventory within a year. Telix Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2023 was 7.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Telix Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.05.

Telix Pharmaceuticals Change In Inventory Historical Data

The historical data trend for Telix Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telix Pharmaceuticals Change In Inventory Chart

Telix Pharmaceuticals Annual Data

Trend

Sep99

Sep00

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

Telix Pharmaceuticals Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial								-	-	-	-	-

Telix Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

Telix Pharmaceuticals (OTCPK:TLPPF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Telix Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	10.022	/	72.543	*	365 / 2
	=	25.21

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Telix Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	72.543	/	10.022
	=	7.24

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Telix Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	10.022	/	186.311
	=	0.05

Telix Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of Telix Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Telix Pharmaceuticals (Telix Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telix Pharmaceuticals Ltd (OTCPK:TLPPF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

TLX:Australia

Address

55 Flemington Road, Suite 401, North Melbourne, Melbourne, VIC, AUS, 3051

Website

https://www.telixpharma.com

Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.